Adams Asset Advisors’s Pfizer PFE Stock Holding History

Adams Asset Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.31M	Buy	345,049 +3,504	+1%	+$91.7K	0.94%	31
2026 Q1	$9.59M	Buy	341,545 +384	+0.1%	+$10.2K	1.08%	30
2025 Q4	$8.49M	Hold	341,161	–	–	1.12%	28
2025 Q3	$8.69M	Buy	341,161 +45,242	+15%	+$1.12M	1.12%	29
2025 Q2	$7.17M	Sell	295,919 -52,030	-15%	-$1.21M	1.01%	32
2025 Q1	$8.82M	Buy	347,949 +5,803	+2%	+$152K	1.21%	30
2024 Q4	$9.08M	Buy	342,146 +32,802	+11%	+$890K	1.17%	27
2024 Q3	$8.95M	Buy	309,344 +3,125	+1%	+$91.2K	1.18%	27
2024 Q2	$8.57M	Sell	306,219 -5,542	-2%	-$153K	1.12%	26
2024 Q1	$8.65M	Buy	311,761 +1,074	+0.3%	+$29.8K	1.12%	28
2023 Q4	$8.94M	Buy	310,687 +95,465	+44%	+$2.89M	1.2%	27
2023 Q3	$7.14M	Buy	215,222 +29,334	+16%	+$1.04M	0.96%	29
2023 Q2	$6.82M	Sell	185,888 -15,008	-7%	-$584K	1%	29
2023 Q1	$8.2M	Hold	200,896	–	–	1.1%	25
2022 Q4	$10.3M	Sell	200,896 -866	-0.4%	-$41.5K	1.38%	16
2022 Q3	$8.83M	Buy	201,762 +2,110	+1%	+$103K	1.37%	15
2022 Q2	$10.5M	Buy	199,652 +813	+0.4%	+$41.4K	1.59%	14
2022 Q1	$10.3M	Hold	198,839	–	–	1.51%	15
2021 Q4	$11.7M	Sell	198,839 -58,011	-23%	-$2.87M	2.14%	6
2021 Q3	$11M	Sell	256,850 -2,198	-0.8%	-$97.4K	2.23%	6
2021 Q2	$10.1M	Buy	259,048 +31,804	+14%	+$1.24M	1.99%	8
2021 Q1	$8.23M	Sell	227,244 -3,406	-1%	-$121K	1.77%	17
2020 Q4	$8.49M	Sell	230,650 -13,899	-6%	-$510K	2.32%	7
2020 Q3	$8.52M	Hold	244,549	–	–	2.7%	4
2020 Q2	$7.59M	Buy	244,549 +43,667	+22%	+$1.48M	2.25%	8
2020 Q1	$6.22M	Buy	200,882 +18,677	+10%	+$636K	2.49%	7
2019 Q4	$6.77M	Buy	182,205 +16,299	+10%	+$581K	1.18%	19
2019 Q3	$5.66M	Buy	165,906 +4,550	+3%	+$165K	0.92%	25
2019 Q2	$6.63M	Sell	161,356 -2,194	-1%	-$87.1K	1.02%	20
2019 Q1	$6.59M	Sell	163,550 -502	-0.3%	-$20.1K	0.88%	20
2018 Q4	$6.79M	Sell	164,052 -2,182	-1%	-$90.6K	0.96%	14
2018 Q3	$6.95M	Buy	166,234 +1,246	+0.8%	+$48K	0.75%	21
2018 Q2	$5.68M	Buy	164,988 +33,545	+26%	+$1.15M	0.61%	30
2018 Q1	$4.42M	Hold	131,443	–	–	0.6%	37
2017 Q4	$4.52M	Hold	131,443	–	–	0.56%	37
2017 Q3	$4.45M	Buy	131,443 +5,937	+5%	+$191K	0.61%	34
2017 Q2	$4M	Hold	125,506	–	–	0.59%	36
2017 Q1	$4.07M	Hold	125,506	–	–	0.58%	34
2016 Q4	$3.87M	Hold	125,506	–	–	0.51%	37
2016 Q3	$4.03M	Hold	125,506	–	–	0.56%	31
2016 Q2	$4.19M	Sell	125,506 -1,518	-1%	-$48.4K	0.72%	31
2016 Q1	$3.57M	Hold	127,024	–	–	0.67%	30
2015 Q4	$3.89M	Hold	127,024	–	–	0.74%	29
2015 Q3	$3.79M	Sell	127,024 -4,051	-3%	-$130K	0.71%	30
2015 Q2	$4.17M	Hold	131,075	–	–	0.77%	32
2015 Q1	$4.33M	Hold	131,075	–	–	0.82%	34
2014 Q4	$3.87M	Sell	131,075 -273	-0.2%	-$7.83K	0.69%	35
2014 Q3	$3.68M	Hold	131,348	–	–	0.62%	37
2014 Q2	$3.7M	Hold	131,348	–	–	0.65%	30
2014 Q1	$4M	Sell	131,348 -35,570	-21%	-$1.06M	0.69%	30
2013 Q4	$4.85M	Sell	166,918 -14,928	-8%	-$434K	0.82%	23
2013 Q3	$4.96M	Sell	181,846 -55,840	-23%	-$1.52M	0.87%	20
2013 Q2	$6.32M	Buy	+237,686	New	+$6.57M	0.98%	19

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Adams Asset Advisors's PFE Position: Q2 2026 in Review

Adams Asset Advisors increased its Pfizer (PFE) stake by 1% in Q2 2026, buying an estimated $91.7K and bringing the position to 345,049 shares worth $8.31M. The position accounts for 0.94% of the portfolio, ranked #31.

Adams Asset Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.7M in Q4 2021. 705 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Adams Asset Advisors held 345,049 shares of Pfizer worth $8.31M as of Q2 2026.
Adams Asset Advisors bought 3,504 Pfizer shares in Q2 2026, an estimated $91.7K.
Pfizer made up 0.94% of Adams Asset Advisors's portfolio in Q2 2026, its #31 holding.
Adams Asset Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Adams Asset Advisors's Pfizer position peaked at $11.7M in Q4 2021.
705 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Adams Asset Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.